Ganymed Pharmaceuticals AG   Report issue

For profit Phase 1 Phase 2
Founded: Mainz Germany (2001)
Status: Acquired by Astellas (2016) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
2009
NCT00909025
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 1)

Ovarian Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 7